Greenwich LifeSciences, Inc. (GLSI)
NASDAQ: GLSI · Real-Time Price · USD
27.73
-0.26 (-0.93%)
At close: Feb 11, 2026, 4:00 PM EST
27.09
-0.64 (-2.31%)
Pre-market: Feb 12, 2026, 8:26 AM EST
Greenwich LifeSciences Market Cap
Greenwich LifeSciences has a market cap or net worth of $384.19 million as of February 12, 2026. Its market cap has increased by 122.60% in one year.
Market Cap
384.19M
Enterprise Value
380.38M
1-Year Change
122.60%
Ranking
Category
Stock Price
$27.73
Market Cap Chart
Since the IPO on September 25, 2020, Greenwich LifeSciences's market cap has increased from $68.69M to $384.19M, an increase of 459.32%. That is a compound annual growth rate of 37.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 384.19M | 31.98% |
| Dec 31, 2025 | 291.08M | 97.19% |
| Dec 31, 2024 | 147.61M | 9.21% |
| Dec 29, 2023 | 135.16M | -30.79% |
| Dec 30, 2022 | 195.29M | -38.84% |
| Dec 31, 2021 | 319.29M | -31.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Absci | 395.48M |
| Bicycle Therapeutics | 395.40M |
| Enanta Pharmaceuticals | 389.72M |
| Aclaris Therapeutics | 388.96M |
| Immutep | 382.25M |
| Entrada Therapeutics | 381.21M |
| Anavex Life Sciences | 377.94M |
| Autolus Therapeutics | 375.26M |